135 related articles for article (PubMed ID: 7933789)
1. [Differences in hemodynamic effects of the cardioselective beta-adrenoblocker acebutolol and non-selective beta-adrenoblocker propranolol in long-term antihypertensive therapy].
Metelitsa VI; Duda SG; Ostrovskaia TP; Malysheva NV; Lerman OV; Shastun RS; Manoshkina EM; Piotrovskiĭ VK; Rumiantsev DO; Belolipetskaia VG
Kardiologiia; 1993; 33(4):32-8. PubMed ID: 7933789
[TBL] [Abstract][Full Text] [Related]
2. [Pharmaco -- genetic approach to the improvement of beta-adrenoblocker therapy in the treatment of hypertension].
Filippenko NG; Povetkin SV; Smirnova II; Dementéva NG; Bredikhin VT
Kardiologiia; 1993; 33(5):30-2. PubMed ID: 7967324
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic effects of acebutolol and propranolol.
Nigri A; Mangieri E; Martuscelli E; Reale A
Clin Ther; 1984; 6(5):693-8. PubMed ID: 6478471
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the acute effects of acebutolol and propranolol on blood pressure, heart rate and hormonal changes during graded treadmill exercise in patients with essential hypertension.
Matsuura H; Masaoka S; Kanazawa I; Murano S; Tsuchioka Y; Kajiyama G
Jpn J Med; 1989; 28(1):8-15. PubMed ID: 2657144
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
[TBL] [Abstract][Full Text] [Related]
7. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
Metelitsa VI; Duda SG; Gorbunov VM; Buchner-Moll D; Deev AD; Vygodin VA; Filatova NP; Chel'dieva EIa; Shastun RS; Simonov DV
Eksp Klin Farmakol; 1995; 58(2):32-4. PubMed ID: 7773086
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
Reim HG; Wagner W
Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
[TBL] [Abstract][Full Text] [Related]
9. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
Gülker H; Kristek J; Heuer H; Bender F
Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients.
Abengowe CU
J Int Med Res; 1985; 13(2):116-21. PubMed ID: 2860041
[TBL] [Abstract][Full Text] [Related]
11. [Doppler echocardiography in assessing the effect of the beta 1-selective adrenoblocker acebutolol on left-ventricular diastolic filling in hypertension patients].
Alekhin MN; Sedov VP; Bozh'ev AM; Sidorenko EA
Ter Arkh; 1997; 69(4):15-8. PubMed ID: 9213947
[No Abstract] [Full Text] [Related]
12. A cross-over trial comparing the effects of acebutolol and propranolol on the serum lipids and hypertension.
Ghosh DC; Dutta S; Sarkar N
Indian Heart J; 1989; 41(5):292-5. PubMed ID: 2599537
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
Whitsett TL; Levin DC; Manion CV
Chest; 1982 Dec; 82(6):668-73. PubMed ID: 6128186
[TBL] [Abstract][Full Text] [Related]
14. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
Takami N; Sugawara K; Ozaki M
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
[TBL] [Abstract][Full Text] [Related]
15. Ancillary pharmacologic properties of acebutolol: cardioselectivity, partial agonist activity, and membrane-stabilizing activity.
Giacomini JC; Thoden WR
Am Heart J; 1985 May; 109(5 Pt 2):1137-44. PubMed ID: 2859777
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacology of acebutolol in animals].
Basil B
Nouv Presse Med; 1975 Dec; 4(46 Suppl):3217-21. PubMed ID: 1219628
[TBL] [Abstract][Full Text] [Related]
17. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
[TBL] [Abstract][Full Text] [Related]
18. [Acebutolol in the therapy of mild and moderate hypertension].
Widimský J
Vnitr Lek; 1994 Jan; 40(1):14-6. PubMed ID: 8140743
[TBL] [Abstract][Full Text] [Related]
19. Effects of equipotent blocking doses of acebutolol, acebutolol's primary metabolite, and propranolol on left ventricular hemodynamics in conscious awake dogs.
Magder S; Rubenson D; Griffin G; Kernoff R; Harrison DC
J Cardiovasc Pharmacol; 1983; 5(4):691-6. PubMed ID: 6193369
[TBL] [Abstract][Full Text] [Related]
20. Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Tsukiyama H; Otsuka K; Horii M; Yoshii Y; Hatori Y; Nakamura Y; Nemoto E; Yamato T; Sakai T; Yamamoto Y
Jpn Circ J; 1983 Mar; 47(3):313-22. PubMed ID: 6132016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
